| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |